HYQVIA

immunoglobulin G (IgG) with recombinant human hyaluronidase · Shire (Baxalta)

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for HYQVIA, covering 2016-08-31 to 2026-06-05. Get the full timeline:

Most recent: EMA Authorised: HyQvia (human normal immunoglobulin) — Baxalta Innovations GmbH